Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

Cutting-edge therapies exist, but the market cannot deliver them cheaply. Britain must build NHS capacity so that cures become collective goods, not expensive products Just a small fraction of our ...

More refined AI models, advancements in human gene editing and the continuing impact of the Trump Team on science — we run ...

In the latest in our imagined history of inventions yet to come, Future Chronicles columnist Rowan Hooper reveals how by the ...

Live Science's health channel editor makes predictions about the medical breakthroughs and public health shifts to come in ...

According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

Immense progress in gene editing, drug discovery and conservation are just some of the reasons to be cheerful about 2025 ...

Scientists and physicians can better assess precision genome editing technology using a new method made public today by St.

CRISPR Therapeutics reached a significant milestone a couple of years ago: its first product approval. The company’s stock, ...

Scientists from Kolkata-based Bose Institute have created GlowCas9 -- a CRISPR protein that lights up while performing gene editing -- to help boost treatment of genetic diseases and cancer, said the ...